Please see below all current urogenital and prostate cancer clinical trials of the Central Coast Cancer Centre.
A Phase 2, Open-Label, Single-Arm Study of Pamiparib (BGB-290) for the Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) with Homologous Recombination Deficiency (HRD).
Principal Investigator: Dr Matthew Chan
Study Coordinator: Richard Clayton
Condition: Prostate cancer
More information about this trial
For more information about medical oncology clinical trials, please contact the Nurse Unit Manager on 02 4320 9890 or see: